Drug intelligence / Profile preview

fluocortolone + lidocaine

Development stage
Unknown
Lead developer
Bayer
Modality
Small Molecules
Administration
Rectal, Topical (perianal)
01

Overview

**Fluocortolone + lidocaine** is a combination drug comprised of a synthetic corticosteroid (fluocortolone typically as the pivalate and/or caproate ester) and a local amide anesthetic (lidocaine). It is primarily indicated for the local treatment of hemorrhoids and other anorectal inflammatory conditions. Fluocortolone exerts anti-inflammatory, antiallergic, and antipruritic effects through glucocorticoid receptor agonism, thereby reducing swelling, redness, and itching in affected tissues. Lidocaine provides fast-acting, reversible local anesthesia by blocking voltage-gated sodium channels in neuronal cell membranes, which suppresses pain and itching at the site of application. The combination provides both anti-inflammatory and rapid symptomatic relief, and is available as a cream and suppository for rectal and perianal administration. The combination is widely used in Europe, Latin America, and other regions but not approved in the United States.

Brand names
Ultraproct
Other names
fluocortolone pivalate + lidocainefluocortolone caproate + lidocaine
02

Targets

GR (Glucocorticoid receptor)SCN3A (Sodium channel protein type 3 subunit alpha)

Beyond the preview

Go deeper on fluocortolone + lidocaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluocortolone + lidocaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call